[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100486072":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":12,"responsibleParty":44,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":15,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"University of Oxford","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"iron-deficient",null,"patients prescribed intravenous iron infusion for the treatment of iron deficiency as part of standard clinical care",[13],{"facility":14,"status":15,"city":16,"state":17,"zip":18,"country":19,"countryCode":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"Oxford Centre for Clinical Magnetic Resonance Research (OCMR)","RECRUITING","Oxford","Oxfordshire","OX3 9DU","United Kingdom","UK",{"type":22,"coordinates":23},"Point",[24,25],-1.25596,51.75222,{"lat":25,"lon":24},[28,33,36,38,40,42],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Samira Lakhal-Littleton","CONTACT","01865 221172","samira.lakhal-littleton@dpag.ox.ac.uk",{"name":34,"role":35,"phone":10,"phoneExt":10,"email":10},"Vanessa Ferreira","SUB_INVESTIGATOR",{"name":37,"role":35,"phone":10,"phoneExt":10,"email":10},"Akshay Shah",{"name":39,"role":35,"phone":10,"phoneExt":10,"email":10},"Paolo Polzella",{"name":41,"role":35,"phone":10,"phoneExt":10,"email":10},"Michael Desborough",{"name":43,"role":35,"phone":10,"phoneExt":10,"email":10},"Stefan Piechnik",{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100486072","imaging-intravenous-iron-100486072",false,"NCT05609318","Imaging Intravenous Iron","Study of Tissue Iron Uptake in Iron-Deficient Patients Receiving Intravenous Iron Replacement Therapy: A Prospective Observational Study (STUDY)","Inclusion Criteria:\n\n* Participant is willing and able to give informed consent for participation in the study.\n* Aged 18 years or above.\n* Anaemia (haemoglobin less than 120g\u002FL for women and less than 130g\u002FL for men) and\u002For confirmed iron deficiency (ferritin less than 100mcg\u002FL and\u002For transferrin saturation less than 20%).\n* Scheduled to receive intravenous iron for correction of iron deficiency.\n\nExclusion Criteria:\n\n* Any MRI incompatible implants (e.g. cardiac, neuro, ocular implants, surgical clips, aneurysm clips, shrapnel\u002Fbullets)\n* Pregnant or lactating participant\n* Acute decompensated heart failure\n* Unstable clinical status\n* Any other medical conditions which would influence the reliability of the study results determined by the investigators.\n* Any other contraindication to MRI to be confirmed by the qualified MRI operator, e.g. tattoos containing traces of metal.","ALL","18 Years",{"count":56,"type":57},12,"ESTIMATED","6 Weeks","OBSERVATIONAL","The aim of this study is to track where the iron goes in different tissues in the hours, days and weeks after an intravenous iron infusion. We will track iron in tissues using MRI relaxometry parameters R1\u002FR2\u002FR2\\* which are well established as accurate indicators of tissue iron content.",[62],"Iron-deficiency","2026-05-06",{"date":65,"type":66},"2026-05-11","ACTUAL",{"date":68,"type":66},"2022-10-29",{"date":70,"type":57},"2026-12-31",{"name":5,"class":6},1]